Company / AR per Share
MADRIGAL PHARMACEUTICALS, INC. AR per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$6.11
FY2025
5-year range
$0.00 / $6.11
FY2023-FY2025
Trend
+125.7%
vs FY2024
Sector context
#15 of 113
Health Care
What the data says
MADRIGAL PHARMACEUTICALS, INC.'s ar per share of $6.11 is higher than 87% of companies in the Health Care sector (FY2025). Improved from $0.00 to $6.11 over the past 2 years.
Based on SEC 10-K filings.
6.11 in FY2025. Top quartile in the Health Care sector.
Improved from $0.00 to $6.11 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 113This company $6.11 Sector average $28.83
▼
-78.8% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 125.7% year-over-year.
- Ranks #15 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.11 | +125.7% |
| FY2024 | $2.71 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026